The emerging approach of this peptide represents a exciting advance in the care of the condition. Unlike existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP – leading to https://tirzepatidepeptide820550.ka-blogs.com/95552565/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment